← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #1614 OF 1,916 MOST-CITED

Notification w/in 8 weeks

FDA cited this observation 7 times across 7 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Biologics7
BY FISCAL YEAR
FY20261
FY20252
FY20231
FY20221
FY20201
FY20161

How FDA worded it — real examples

Failure to make reasonable attempts to notify the donor within 8 weeks after determining that the donor was deferred or determined not to be eligible for donation.

B Positive National Blood Services - Wilkes Barre, LLC · Edwardsville, Pennsylvania · Biologics · 2025-10-29

Failure to make reasonable attempts to notify the donor within 8 weeks after determining that the donor was deferred or determined not to be eligible for donation.

Department of Defense - Air Force · Dayton, Ohio · Biologics · 2025-04-14

Failure to make reasonable attempts to notify the donor within 8 weeks after determining that the donor was deferred or determined not to be eligible for donation.

Memorial Hospital For Cancer & Allied Diseases · New York, New York · Biologics · 2025-02-13

Failure to make reasonable attempts to notify the donor within 8 weeks after determining that the donor was deferred or determined not to be eligible for donation.

ABO Plasma Glassboro LLC · Glassboro, New Jersey · Biologics · 2023-03-14

Failure to make reasonable attempts to notify the donor within 8 weeks after determining that the donor was deferred or determined not to be eligible for donation.

Continental Services Group, Inc. · Ft Lauderdale, Florida · Biologics · 2022-08-24

Failure to make reasonable attempts to notify the donor within 8 weeks after determining that the donor was deferred or determined not to be eligible for donation.

Specialty Blood Center · Charleston, South Carolina · Biologics · 2019-12-16

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Biologics industry

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →